CLINICAL_TRIALS
trial_result
· 2012-10-17
Clinical Trial Update: Curative Effect Study of Endostatin Combined With Chemoradiotherapy to Non-small-cell Lung Cancer [Phase 2]
Summary
Phase 2 trial results evaluate endostatin in combination with chemoradiotherapy for non-small cell lung cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sun Yat-sen University | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: UNKNOWN | Results posted: 2012-10-17